New Fogarty Company Addresses $1.75 Billion Chronic Sinusitis Market — Nasus Medical

News & Events Contact

About Leadership

Intranasal Drug Delivery Drug Delivery Device

Chronic Sinusitis Other Disease States

Company About Leadership Technology Intranasal Drug Delivery Drug Delivery Device Therapeutic Areas Chronic Sinusitis Other Disease States News & Events Contact

Empowering patients with innovative ENT solutions

New Fogarty Company Addresses $1.75 Billion Chronic Sinusitis Market

Fogarty InstituteShira KossMay 11, 2020

Facebook0 Twitter 0 Likes

MedTech Innovator Announces Top 50 Medtech Startups Selected for Annual Showcase and Accelerator

MedTech InnovatorShira KossJune 22, 2020

Logo_White version.png

COMPANY
About
Leadership
News & Events

TECHNOLOGY
Intranasal Drug Delivery
Drug Delivery Device

THERAPEUTIC AREAS
Chronic Sinusitis
Other Disease States

©2021 Nasus Medical

Powered by Squarespace

Copyright © 2020 Nasus Medical.

Copyright 2021 Nasus Medical

Copyright 2021 Nasus Medical

Copyright 2021 Nasus Medical

Copyright 2021 Nasus Medical

©2021 Nasus Medical

©2021 Nasus Medical